In the News

1850 News Items found
Hundreds of high school students and teachers from the New York City area attend the annual seminar.
Event
For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world.
Pictured: Ping Chi
Q&A
At Work: Physician-Scientist Ping Chi
Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.
Pictured: Scott Armstrong
Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair.
Pictured: Zuckerman Research Center
Announcement
Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer.
Pictured: Structure of Synthesized Erythropoietin
In the Lab
Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.
Pictured: Alexander Rudensky
Announcement
Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.
Pictured: Tunneling Nanotubes
Snapshot
Tunneling Nanotubes Connect Cancer Cells
Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
Pictured: Ross Levine
In the Lab
Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.
Pictured: Natural Killer Cells & Cancer Cell
In the Lab
In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.
Pictured: Filippo Giancotti
In the Lab
A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.